Immune therapy trial with Corynebacterium in patients with E.N.T. cancer. (Code name of the trial: "Reticulo-stimuline")
Mahé, E.; Sachwald, J.; Brunet, M.; Clavel, B.; Debaud, B.; Meeus, L.
Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 95(9): 629-635
1978
ISSN/ISBN: 0003-438X PMID: 371488 Document Number: 125249
Document emailed within 1 workday
Related Documents
Hu, D.; Xu, Z. 1997: Multicenter clinical trial of thrombolytic therapy in 1,406 patients with acute myocardial infarction. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(11): 839-842Locker, G.Y.; Khandekar, J.; Krauss, S.; Reisel, H.; Hoeltgen, T.; Wolter, J.; Haid, M.; Hoffman, R.; Blough, R.; Johnson, C. 1987: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial Cancer Treatment Reports 71(6): 649-650
Minton, J.P.; Rossio, J.L.; Dixon, B.; Dodd, M.C. 1976: The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer Clinical and Experimental Immunology 24(3): 441-447
Medenica, R.; Girard, J.P.; Maurice, P. 1977: Clinical trial with Corynebacterium parvum Developments in Biological Standardization 38: 483-485
Wu, S.F.; Yu, M.P.; Tai, H.M.; Cheng, Y.R.; Ye, Q.W.; Che, Y.F.; Bao, L.P.; Zhang, G.C. 1979: Clinical trial of the treatment of lung cancer with xenogeneic immune RNA Zhonghua Zhong Liu Za Zhi 1(2): 150-155
Gianni, L.; Munzone, E.; Capri, G.; Villani, F.; Spreafico, C.; Tarenzi, E.; Fulfaro, F.; Caraceni, A.; Martini, C.; Laffranchi, A. 1995: Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines Journal of the National Cancer Institute 87(15): 1169-1175
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lester, R.T.; Mills, E.J.; Smieja, M.; Dolovich, L.; Kouanfack, C. 2012: The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy Plos one 7(12): E46909
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145
Katayose, Y.; Yamamoto, K.; Nakagawal, K.; Takemura, S.; Takahashi, M.; Nakamura, R.; Shimamura, H.; Rikiyama, T.; Egawa, S.; Yoshda, H.; Motoi, F.; Naitoh, T.; Unno, M. 2015: Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001) Hepato-Gastroenterology 62(138): 303-308
Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25
Rabkin, J.G.; Wagner, G.; Rabkin, R. 1994: Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial Journal of Clinical Psychiatry 55(10): 433-439
Bieber, T.; Chosidow, O.; Bodsworth, N.; Tyring, S.; Hercogova, J.; Bloch, M.; Davis, M.; Lewis, M.; Boutolleau, D.; Attali, P.; Bisshop, F.R.; Bloch, M.T.; Bodworth, N.J.; Aster, V.; Asterova, J.; Hercogova, J.; Klimesova, R.; Krajsova, I.; Ben Slama, L.; Cambazard, F.; Chosidow, O.; Dubertret, L.; Granel, F.; Humbert, P.; Ortonne, J.P.; Rostain, G.; Ruer-Mulard, M.; Vaillant, L.; Beiber, T.; Degen, A.J.; Dörzapf, O.; von Hake, G.; Miller, A.; Naudts, I.; Steinert, M.; Stockfleth, E.; Weihe, J.; Wunderlich, U.; Jasieniak-Pinis, G.; Kazina, M.; Pawlaczyk-Strugala, E.; Placek, W.; Petryka, R.; Romanowski, L.; Dixon, C.J.; Lewis, M.; Sharma, R.; Archuleta, M.; Baker, D.A.; Cady, R.K.; Conant, M.A.; Crump, W.L.; Davis, M.G.; Dunlap, F.E.; Lee 2014: Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial Journal of Drugs in Dermatology: Jdd 13(7): 791-798
Thatcher, N.; Swindell, R.; Crowther, D. 1979: Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions Clinical and Experimental Immunology 36(2): 227-236
Sasagawa, T.; Ho, N.; Endo, T.; Sekine, T.; Sugiyama, K.; Tomidokoro, T.; Hatakeyama, S.; Togashi, M.; Onuki, K.; Katagiri, J. 1994: Randomized controlled trial of MMC + UFT and MMC + 5-FU therapy in advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(8): 1179-1185
Federico, M.; Clò, V.; Carella, A.M. 1996: High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial Leukemia 10 Suppl. 2: S69-S71
Luckett, T.; Phillips, J.; Agar, M.; Lam, L.; Davidson, P.M.; McCaffrey, N.; Boyle, F.; Shaw, T.; Currow, D.C.; Read, A.; Hosie, A.; Lovell, M. 2018: Protocol for a phase III pragmatic stepped wedge cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of screening and guidelines with, versus without, implementation strategies for improving pain in adults with cancer attending outpatient oncology and palliative care services: the Stop Cancer PAIN trial Bmc Health Services Research 18(1): 558
Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Pannuti, F.; Martoni, A.; Piana, E.; Tomasi, L.; Grieco, A.; Farris, A.; Saccani, F.; Baroni, M. 1984: Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(4): 211-215
Lung, T.; Jan, S.; de Silva, H.A.; Guggilla, R.; Maulik, P.K.; Naik, N.; Patel, A.; de Silva, A.P.; Rajapakse, S.; Ranasinghe, G.; Prabhakaran, D.; Rodgers, A.; Salam, A.; Selak, V.; Stepien, S.; Thom, S.; Webster, R.; Lea-Laba, T. 2019: Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial LANCET. Global Health 7(10): E1359-E1366
Mustacchi, G.; Milani, S.; Pluchinotta, A.; De Matteis, A.; Rubagotti, A.; Perrota, A. 1994: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly Anticancer Research 14(5b): 2197-2200